Walker, T D J, Faraahi, Z F, Price, M J, Hawarden, A, Waddell, C A, Russell, B, Jones, D M, McCormick, A, Gavrielides, N, Tyagi, S, Woodhouse, L C, Whalley, B, Roberts, C, Crosbie, E J & Edmondson, R J 2023, ' The DNA damage response in advanced ovarian cancer: functional analysis combined with machine learning identifies signatures that correlate with chemotherapy sensitivity and patient outcome ', British Journal of Cancer . https://doi.org/10.1038/s41416-023-02168-3
Edmondson, R & Hawarden, A 2021, ' Propensity score matching confirms that primary surgery or neoadjuvant chemotherapy result in equivalent survival within a comprehensive cohort of patients with high-grade serous ovarian cancer ', Gynecologic Oncology, vol. 160, no. 1, pp. 24-31 . https://doi.org/10.1016/j.ygyno.2020.10.035
Scott, R, Hawarden, A, Russell, B & Edmondson, R 2019, ' Decision-making in gynaecological oncology multidisciplinary team meetings: a cross sectional, observational study of ovarian cancer cases ', Oncology Research and Treatment, vol. 19 . https://doi.org/10.1159/000504260
BMC Cancer Hawarden, A, Russell, B, Gee, M E, Skayali, F, Clamp, A, Crosbie, E & Edmondson, R 2021, ' Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study ', BMC Cancer . https://doi.org/10.1186/s12885-021-08019-9 BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)